HyQvia 100 mg/ml
HyQvia 100 mg/ml is a medicine authorised by Swissmedic under authorisation number 66684. The authorisation holder is Takeda Pharma AG. The medicinal product code is Blood products and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 08 January 2020 and the authorisation is valid without a time limit. ATC code J06BA01 places the medicine in the group Immune sera and immunoglobulins.
| Authorisation number | 66684 |
|---|---|
| Name | HyQvia 100 mg/ml |
| Full name | HyQvia 100 mg/ml, Infusionslösung zur subkutanen Anwendung |
| Authorisation holder | Takeda Pharma AG |
| Medicinal product code | Blood products |
| Dispensing category | B · Prescription only |
| ATC code | J06BA01 |
| First authorisation | 08 January 2020 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | HyQvia 100 mg/ml, Infusionslösung zur subkutanen Anwendung | B | 08 January 2020 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 + 1 | Durchstechflasche(n) | J06BA01 | 08.09. | B |
| 2 | 1 + 1 | Durchstechflasche(n) | J06BA01 | 08.09. | B |
| 3 | 1 + 1 | Durchstechflasche(n) | J06BA01 | 08.09. | B |
| 4 | 1 + 1 | Durchstechflasche(n) | J06BA01 | 08.09. | B |
| 5 | 1 + 1 | Durchstechflasche(n) | J06BA01 | 08.09. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is HyQvia 100 mg/ml authorised in Switzerland?
Yes. HyQvia 100 mg/ml is authorised by Swissmedic under authorisation number 66684, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does HyQvia 100 mg/ml have?
HyQvia 100 mg/ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of HyQvia 100 mg/ml?
The authorisation holder is Takeda Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.